385 related articles for article (PubMed ID: 22394685)
21. Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines.
Muguruma M; Teraoka S; Miyahara K; Ueda A; Asaoka M; Okazaki M; Kawate T; Kuroda M; Miyagi Y; Ishikawa T
Biochem Biophys Res Commun; 2020 Dec; 533(3):268-274. PubMed ID: 32958246
[TBL] [Abstract][Full Text] [Related]
22. Therapeutically blocking Interleukin-11 Receptor-α enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours.
Winship A; Van Sinderen M; Rainczuk K; Dimitriadis E
Oncotarget; 2017 Apr; 8(14):22716-22729. PubMed ID: 28186993
[TBL] [Abstract][Full Text] [Related]
23. Loss of AF-6/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancer.
Yamamoto T; Mori T; Sawada M; Matsushima H; Ito F; Akiyama M; Kitawaki J
BMC Cancer; 2015 Apr; 15():275. PubMed ID: 25879875
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.
Härmä V; Virtanen J; Mäkelä R; Happonen A; Mpindi JP; Knuuttila M; Kohonen P; Lötjönen J; Kallioniemi O; Nees M
PLoS One; 2010 May; 5(5):e10431. PubMed ID: 20454659
[TBL] [Abstract][Full Text] [Related]
25. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer.
Sogawa C; Eguchi T; Namba Y; Okusha Y; Aoyama E; Ohyama K; Okamoto K
Cells; 2021 Feb; 10(2):. PubMed ID: 33562088
[TBL] [Abstract][Full Text] [Related]
26. Development of a drug resistance model for hepatoblastoma.
Eicher C; Dewerth A; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
Int J Oncol; 2011 Feb; 38(2):447-54. PubMed ID: 21132272
[TBL] [Abstract][Full Text] [Related]
27. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
Frankel A; Buckman R; Kerbel RS
Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815
[TBL] [Abstract][Full Text] [Related]
28. Analogs of a Natural Peptaibol Exert Anticancer Activity in Both Cisplatin- and Doxorubicin-Resistant Cells and in Multicellular Tumor Spheroids.
Casagrande N; Borghese C; Gabbatore L; Morbiato L; De Zotti M; Aldinucci D
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445069
[TBL] [Abstract][Full Text] [Related]
29. Interaction of human trophoblast cells with gland-like endometrial spheroids: a model system for trophoblast invasion.
Buck VU; Gellersen B; Leube RE; Classen-Linke I
Hum Reprod; 2015 Apr; 30(4):906-16. PubMed ID: 25662813
[TBL] [Abstract][Full Text] [Related]
30. Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance.
van Oosterwijk JG; Herpers B; Meijer D; Briaire-de Bruijn IH; Cleton-Jansen AM; Gelderblom H; van de Water B; Bovée JV
Ann Oncol; 2012 Jun; 23(6):1617-26. PubMed ID: 22112972
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
Rouette A; Parent S; Girouard J; Leblanc V; Asselin E
Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512
[TBL] [Abstract][Full Text] [Related]
32. AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.
Godugu C; Patel AR; Desai U; Andey T; Sams A; Singh M
PLoS One; 2013; 8(1):e53708. PubMed ID: 23349734
[TBL] [Abstract][Full Text] [Related]
33. Ca
Ohya S; Kajikuri J; Endo K; Kito H; Elboray EE; Suzuki T
Cancer Sci; 2021 Sep; 112(9):3769-3783. PubMed ID: 34181803
[TBL] [Abstract][Full Text] [Related]
34. Laminin-1-derived scrambled peptide AG73T disaggregates laminin-1-induced ovarian cancer cell spheroids and improves the efficacy of cisplatin.
Yoshida Y; Kurokawa T; Nishikawa Y; Orisa M; Kleinman HK; Kotsuji F
Int J Oncol; 2008 Mar; 32(3):673-81. PubMed ID: 18292945
[TBL] [Abstract][Full Text] [Related]
35. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
36. PTEN augments doxorubicin-induced apoptosis in PTEN-null Ishikawa cells.
Wan X; Li J; Xie X; Lu W
Int J Gynecol Cancer; 2007; 17(4):808-12. PubMed ID: 17359293
[TBL] [Abstract][Full Text] [Related]
37. Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin.
Kowalska K; Habrowska-Górczyńska DE; Kurczewska D; Domińska K; Urbanek KA; Piastowska-Ciesielska AW
Cell Biol Toxicol; 2021 Apr; 37(2):261-275. PubMed ID: 32562081
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
Imamura Y; Mukohara T; Shimono Y; Funakoshi Y; Chayahara N; Toyoda M; Kiyota N; Takao S; Kono S; Nakatsura T; Minami H
Oncol Rep; 2015 Apr; 33(4):1837-43. PubMed ID: 25634491
[TBL] [Abstract][Full Text] [Related]
39. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
Sun Y; Wang C; Yang H; Ma X
Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805
[TBL] [Abstract][Full Text] [Related]
40. Antiproliferative effects of 2-methoxyestradiol alone and in combination with chemotherapeutic agents on human endometrial cancer cells.
Chen CH; Lee WJ; Chang TC; Chen RJ; Chien CH; Chow SN
Eur J Gynaecol Oncol; 2009; 30(3):275-80. PubMed ID: 19697620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
